The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus
The American Journal of MedicinePublished 1 December 2001
Elbert S. Huang, James B. Meigs, Daniel E Singer
Citations164
SJR quartileQ1
SJR score1.00
SNIP1.04
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The evidence from these clinical trials demonstrates that lipid and blood pressure lowering in patients with type 2 diabetes is associated with substantial cardiovascular benefits, and intensive glucose lowering is essential for the prevention of microvascular disease, but improvements in cholesterol and blood pressures are central to reducing cardiovascular disease in these patients.
Abstract
The evidence from these clinical trials demonstrates that lipid and blood pressure lowering in patients with type 2 diabetes is associated with substantial cardiovascular benefits. Intensive glucose lowering is essential for the prevention of microvascular disease, but improvements in cholesterol and blood pressure levels are central to reducing cardiovascular disease in these patients.
Keywords
Medicine
JAMASummary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
27,886 Citations1993Scott M. Grundy
Dairy therapy remains the first line of treatment of high blood cholesterol, and drug therapy is reserved for patients who are considered to be at high risk for CHD, and the fundamental approach to treatment is comparable.
JAMAExecutive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
25,992 Citations2001Evaluation Expert Panel on Detection
The LancetIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
20,069 Citations1998
The effects of intensive blood-glucose control with either sulphonylurea or insulin and conventional treatment on the risk of microvascular and macrovascular complications in patients with type 2 diabetes in a randomised controlled trial were compared.
BMJAssociation of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
8,864 Citations2000Irene Stratton
In patients with type 2 diabetes the risk of diabetic complications was strongly associated with previous hyperglycaemia, with the lowest risk being in those with HbA1c values in the normal range (<6.0%).
New England Journal of MedicinePrevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
7,453 Citations1995James Shepherd, Stuart M. Cobbe +6 more
Treatment with pravastatin significantly reduced the incidence of myocardial infarction and death from cardiovascular causes without adversely affecting the risk of death from noncardiovascular causes in men with moderate hypercholesterolemia and no history of my Cardiac Infarction.
BMJTight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
6,722 Citations1998UK Prospective Diabetes Study Group,
Tight blood pressure control in patients with hypertension and type 2 diabetes achieves a clinically important reduction in the risk of deaths related to diabetes, complications related to Diabetes, progression of diabetic retinopathy, and deterioration in visual acuity.
The LancetEffects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
5,765 Citations1998Lennart Hansson, Alberto Zanchetti +8 more
Intensive lowering of blood pressure in patients with hypertension was associated with a low rate of cardiovascular events and the potential benefit of a low dose of acetylsalicylic acid in the treatment of hypertension was assessed.
Archives of Internal MedicineThe sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
5,669 Citations1997
New England Journal of MedicinePrevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
5,299 Citations1998The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
Pravastatin therapy reduced mortality from coronary heart disease and overall mortality, as compared with the rates in the placebo group, as well as the incidence of all prespecified cardiovascular events in patients with a history of myocardial infarction or unstable angina who had a broad range of initial cholesterol levels.
JAMAPrimary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
5,269 Citations1998John R. Downs, Michael Clearfield +8 more
Lovastatin reduces the risk for the first acute major coronary event in men and women with average TC and LDL-C levels and below-average HDL- C levels and supports the inclusion of HDL-C in risk-factor assessment and the need for reassessment of the National Cholesterol Program guidelines.
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
4,820 Citations1998M R Stearne, S L Palmer +261 more
Three computational fluid methodologies are employed, of varying levels of complexity with coupled 0D boundary conditions, to simulate the haemodynamics within a patient-specific aorta, demonstrating that, in the context of certain clinical questions, the simpler analysis methods may capture the important characteristics of the flow field.
Archives of Internal MedicineThe Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
3,779 Citations1997
In older persons, diuretics are preferred and long-acting dihydropyridine calcium antagonists may be considered and specific therapy for patients with LVH, coronary artery disease, and heart failure are outlined.
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
3,460 Citations1995J Ames S Hepherd, S Tuart M. C Obbe +7 more
New England Journal of MedicineGemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
3,444 Citations1999Hanna E. Bloomfield, Sander J. Robins +10 more
Gemfibrozil therapy resulted in a significant reduction in the risk of major cardiovascular events in patients with coronary disease whose primary lipid abnormality was a low HDL cholesterol level, suggesting that the rate of coronary events is reduced by raising HDL cholesterol levels and lowering levels of triglycerides without lowering LDL cholesterol levels.
The LancetEffects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy
3,195 Citations2000
Ramipril was beneficial for cardiovascular events and overt nephropathy in people with diabetes and the cardiovascular benefit was greater than that attributable to the decrease in blood pressure.
JAMARecommendations of the Panel on Cost-Effectiveness in Health and Medicine
2,448 Citations1996Milton C. Weinstein
The basis for recommendations constituting the reference case analysis, the set of practices developed to guide CEAs that inform societal resource allocation decisions, and the content of these recommendations are described.
Nature Reviews Disease PrimersType 2 diabetes mellitus
2,426 Citations2015Ralph A. DeFronzo, Ele Ferrannini +11 more
The greatest need is for agents that enhance insulin sensitivity, halt the progressive pancreatic β-cell failure that is characteristic of T2DM and prevent or reverse the microvascular complications.
BMJAssociation of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
2,130 Citations2000Amanda Adler
In patients with type 2 diabetes the risk of diabetic complications was strongly associated with raised blood pressure, with the lowest risk being in those with systolic blood pressure less than 120 mm Hg.
The LancetEffect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
2,009 Citations1999Lennart Hansson, Lars Lindholm +11 more
Captopril and conventional treatment did not differ in efficacy in preventing cardiovascular morbidity and mortality and the difference in stroke risk was probably due to the lower levels of blood pressure obtained initially in previously treated patients randomised to conventional therapy.
Diabetes CareThe relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.
1,697 Citations1999Mário Sérgio Soares de Azeredo Coutinho, Hertzel C. Gerstein +2 more
The progressive relationship between glucose levels and cardiovascular risk extends below the diabetic threshold, and the beta-coefficients were combined.
New England Journal of MedicineAn Assessment of Clinically Useful Measures of the Consequences of Treatment
1,676 Citations1988Andreas Laupacis, David L. Sackett +1 more
The goal is to provide a clear picture of the individual components of the immune system and provide a strategy for individualized treatment of these components according to their Kesslerian importance.
Diabetes CareCholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
1,639 Citations1997Kalevi Pyörälà, Terje R. Pedersen +5 more
It is suggested that cholesterol lowering with simvastatin improves the prognosis of diabetic patients with CHD and the absolute clinical benefit achieved by cholesterol lowering may be greater in diabetic than in nondiabetic patients withCHD because diabetic patients have a higher absolute risk of recurrent CHD events and other atherosclerotic events.
Journal of the American College of CardiologyRandomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
1,575 Citations1995Klas Malmberg, Lars Rydén +6 more
Insulin-glucose infusion followed by a multidose insulin regimen improved long-term prognosis in diabetic patients with acute myocardial infarction.
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
1,408 Citations1998M R Stearne, S L Palmer +261 more
BMJEfficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
1,390 Citations1998UK Prospective Diabetes Study Group,
This study provided no evidence that either drug has any specific beneficial or deleterious effect, suggesting that blood pressure reduction in itself may be more important than the treatment used.
New England Journal of MedicineThe Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and Hypertension
1,175 Citations1998Raymond O. Estacio, Barrett W. Jeffers +4 more
In this population of patients with diabetes and hypertension, a significantly higher incidence of fatal and nonfatal myocardial infarction is found among those assigned to therapy with the calcium-channel blocker nisoldipine than among those assign to receive enalapril.
Annals of Internal MedicinePharmacologic Therapy for Type 2 Diabetes Mellitus
1,175 Citations1999Ralph A. DeFronzo
These findings provide unequivocal evidence for hepatic resistance to insulin, and this evidence is substantiated by an impaired ability of insulin to suppress hepatic glucose production, which is the major determinant of the mean day-long blood glucose level.
BMJSystematic Review: Why sources of heterogeneity in meta-analysis should be investigated
1,007 Citations1994Simon G. Thompson
This paper distinguishes between the concepts of clinical and statistical heterogeneity and exemplifies the importance of investigating heterogeneity by using published meta-analyses of epidemiological studies of serum cholesterol concentration and clinical trials of its reduction.
CirculationCardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels
991 Citations1998Ronald Goldberg, Margot J. Mellies +8 more
Diabetic patients and nondiabetic patients with impaired fasting glucose are at high risk of recurrent coronary events that can be substantially reduced by pravastatin treatment.
New England Journal of MedicineEffects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension
946 Citations1999Jaakko Tuomilehto, Daiva Rastenytė +11 more
Antihypertensive treatment with the calcium-channel blocker nitrendipine reduced the risk of cardiovascular events in diabetic and nondiabetic patients and was compared with placebo in this post hoc analysis.
Oxford University Press eBooksMeta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis
928 Citations1999Diana B. Petitti
The techniques of meta-analysis, decision analysis and cost-effectiveness analysis play an increasingly important role in the formulation of clinical practice guidelines and in decisions about health policy and financing.
Diabetes CareOutcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM
861 Citations1998Patrizio Tatti, Marco Pahor +5 more
Fosinopril and amlodipine had similar effects on biochemical measures, but the patients randomized to fos inopril had a significantly lower risk of major vascular events, compared with the patients Randomized to amlODipine.
PubMedLong-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
739 Citations2000Masayoshi Shichiri, Hiroki Kishikawa +2 more
Intensive glycemic control can delay the onset and progression of the early stages of diabetic microvascular complications in Japanese patients with type 2 diabetes.
JAMAEffect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus
538 Citations2000Vivian Fonseca, J Rosenstock +2 more
The data suggest that combination treatment with once-daily metformin-rosiglitazone improves glycemic control, insulin sensitivity, and beta-cell function more effectively than treatment with met formin alone.
Diabetes CareCoronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart Study
514 Citations1992Pekka Koskinen, Matti Mänttäri +4 more
Compared with similarly dyslipidemic nondiabetic subjects, patients with NIDDM are at markedly increased risk of CHD and this elevated risk can be somewhat reduced by gemfibrozil.
American Journal of Public HealthCause-specific mortality in a population-based study of diabetes.
319 Citations1991Scot E. Moss, Ronald Klein +1 more
Diabetic persons experience very high mortality, especially from vascular diseases, compared to the general population, and age-sex standardized mortality ratios in a geographically defined population of younger onset and older onset diabetic persons are examined.
The LancetThe epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is … or is it?
265 Citations1997David M. Nathan, James B. Meigs +1 more
PubMedEffects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
225 Citations1971Genell L. Knatterud, Curtis L. Meinert +3 more
Diabetes CareFasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.
205 Citations1999Jørgen Vildershøj Bjørnholt, Gunnar Erikssen +6 more
Fasting blood glucose values in the upper normal range appears to be an important independent predictor of cardiovascular death in nondiabetic apparently healthy middle-aged men.
DiabetologiaA prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: associated risk factorin
192 Citations1990N. J. Morrish, L. K. Stevens +4 more
Hypertension and proteinuria have the most consistent associations with mortality in the different analyses with the effect of hypertension appearing stronger in Type 1 diabetes andproteinuria in Type 2 diabetes.
JAMAEffects of Hypoglycemic Agents on Vascular Complications in Patients With Adult-Onset Diabetes
192 Citations1978Genell L. Knatterud
There were only minor differences in the occurrence of fatal or nonfatal events among the treatment groups, and lower levels of blood glucose with mean values close to normoglycemia were achieved in the treatment group in which the insulin dosage was adjusted to achieve normoglyCEmia.
Archives of Internal MedicineCardiovascular Events and Correlates in the Veterans Affairs Diabetes Feasibility Trial
188 Citations1997Carlos Abraira
A long-term prospective trial is needed to assess the risk-benefit ratio of intensive insulin therapy for NIDDM in patients who require it.
Annals of Internal MedicineCardiovascular Complications of Diabetes Mellitus: What We Know and What We Need To Know about Their Prevention
103 Citations1996Peter J. Savage
The higher risk for macrovascular disease is shown by findings in two large, longitudinal studies, and patients with mild glucose tolerance abnormalities are important because they comprise more than half of those with abnormal glucose tolerance in the U.S. population.
Annals of Internal MedicineEarly or Deferred Zidovudine Therapy in HIV-Infected Patients without an AIDS-Defining Illness
92 Citations1995John P. A. Ioannidis, Joseph C. Cappelleri +5 more
A meta-analysis of all the available data from double-blind, randomized, placebo-controlled trials that addressed the efficacy of zidovudine as monotherapy in HIV-infected adults without AIDS found that it provided a significant benefit for patients without advanced HIV disease.
DiabetesEffects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
86 Citations1999Byron J. Hoogwerf, Abdelkarim Waness +10 more
Diabetic patients in the Post CABG trial had more CHD risk factors at study entry and higher clinical event rates during the study than nondiabetic patients, and the benefits of aggressive cholesterol lowering in diabetic patients were comparable to those in nondi diabetic patients for both angiographic and clinical end points.
DiabetologiaA prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: causes and death rates
79 Citations1990N. J. Morrish, L. K. Stevens +4 more
The results suggest that the female survival advantage seen in the general population may persist in Type 2 but not in Type 1 diabetes, and standardised mortality ratios for the first and second five year follow-up periods were higher for men than for women in Type2 diabetes but were higher in women than men in Type1.
Archives of Internal MedicineType 2 Diabetes Mellitus
71 Citations1999Timothy C. Fagan, James R. Sowers
Preventive MedicineMortality findings for stepped-care and referred-care participants in the hypertension detection and follow-up program, stratified by other risk factors
70 Citations1985
Findings indicate the broad benefit of vigorous antihypertensive stepped-care treatment for hypertensive patients regardless of the presence or absence of the other major risk factors and underscore the need for comprehensive management of persons with high blood pressure.
Journal of General Internal MedicineCardiovascular disease prevention practices by U.S. physicians for patients with diabetes
63 Citations2000James B. Meigs, Randall S. Stafford
Patients with diabetes visiting U.S. physicians in 1995 and 1996 received somewhat more cardiovascular disease prevention services than patients without diabetes, however, Absolute rates of services remained lower than desired based on national recommendations.
Medical Clinics of North AmericaVASCULAR DISEASE AND LIPIDS IN DIABETES
45 Citations1998Alan J. Garber
Intensive treatment with lipid-regulating agents, particularly HMG-CoA reductase inhibitors, is often necessary to normalize diabetes-associated dyslipidemias.
Journal of HypertensionHow far should blood pressure be reduced in diabetic hypertensive patients?
34 Citations1997Luís M. Ruilope, Rafael García‐Robles
The optimal goal of blood pressure control in diabetics has not been established, but there are indications that it should be lower than the 130/85 mmHg systolic/diastolic pressure recommended by current guidelines.
BMJCardiovascular Complications of Diabetes Mellitus
19 Citations1961Nitish Pathania, Ryan Sachar
Ever since the advent of insulin, cardiovascular complications have commanded increasing attention as a cause of morbidity and mortality among diabetic patients and factors such as lack of treatment in a high percentage of cases and the stressed mildness of diabetes in tropical countries may affect the frequency and pattern of these complications.